Celldex Therapeutics, Inc.
Agonistic antibodies that bind CD40
Last updated:
Abstract:
Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.
Status:
Grant
Type:
Utility
Filling date:
5 Apr 2019
Issue date:
28 Apr 2020